Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Ann Neurol ; 80(2): 185-201, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-27255697

RESUMO

OBJECTIVE: Numerous studies have focused on striatal neurodegeneration in Huntington disease (HD). In comparison, the globus pallidus (GP), a main striatal output nucleus, has received less focus in HD research. This study characterizes the pattern of neurodegeneration in 3 subdivisions of the human GP, and its relation to clinical symptomatology. METHODS: Stereology was used to measure regional atrophy, neuronal loss, and soma neuronal atrophy in 3 components of the GP-the external segment (GPe), internal segment (GPi), and ventral pallidum (VP)-in 8 HD cases compared with 7 matched control cases. The findings in the HD patients were compared with HD striatal neuropathological grade, and symptom scores of motor impairment, chorea, cognition, and mood. RESULTS: Relative to controls, in the HD patients the GPe showed a 54% overall volume decline, 60% neuron loss, and 34% reduced soma volume. Similarly, the VP was reduced in volume by 31%, with 48% neuron loss and 64% reduced soma volume. In contrast, the GPi was less affected, with a 38% reduction in overall volume only. The extent of GP neurodegeneration correlated with increasing striatal neuropathological grade. Decreasing GPe and VP volumes were associated with poorer cognition and increasing motor impairments, but not chorea. In contrast, decreasing GPi volumes were associated with decreasing levels of irritability. INTERPRETATION: The HD gene mutation produces variable degrees of GP segment degeneration, highlighting the differential vulnerability of striato-GP target projections. The relationship established between clinical symptom scores and pallidal degeneration provides a novel contribution to understanding the clinicopathological associations in HD. Ann Neurol 2016;80:185-201.


Assuntos
Globo Pálido/patologia , Doença de Huntington/patologia , Degeneração Neural/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Atrofia/complicações , Atrofia/patologia , Estudos de Casos e Controles , Transtornos Cognitivos/complicações , Transtornos Cognitivos/patologia , Feminino , Humanos , Proteína Huntingtina/genética , Doença de Huntington/complicações , Humor Irritável , Masculino , Pessoa de Meia-Idade , Transtornos Motores/complicações , Transtornos Motores/patologia , Degeneração Neural/complicações , Índice de Gravidade de Doença , Repetições de Trinucleotídeos/genética
2.
Neurobiol Dis ; 96: 67-74, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27569581

RESUMO

BACKGROUND: Huntington's disease (HD) is characterised by variable symptoms and neuropathology of the basal ganglia and cortex. Previously, we have shown that the pattern of pyramidal cell loss in 8 different cortical regions correlates with the phenotypic variability in HD. In the primary motor and anterior cingulate cortices, the pattern of interneuron degeneration correlates with pyramidal cell death and variable HD symptom profiles. OBJECTIVES: This study aimed to examine the pattern of interneuron degeneration in 3 further regions of the HD cortex (primary sensory, superior frontal, superior parietal cortices) to determine whether HD neuropathogenesis was characterised by a general fundamental pattern of cortical interneuron loss, and explore the relationship between cortical interneuron loss with previously determined pyramidal cell loss and clinical heterogeneity. METHODS: Stereological counting was used to quantify 3 sub-populations of calcium-binding protein containing interneurons in 3 cortical human brain regions of 14 HD and 13 control cases as used in our previous studies (Nana et al., 2014; Kim et al., 2014). The HD cases were grouped according to their predominant symptom profile ("motor", "mood", "mixed"). RESULTS: The present results demonstrated a heterogeneous loss of interneurons across the 3 cortical regions which, when compared with our previous studies, mirrored the pattern of pyramidal cell loss in the same cortical areas. Most interestingly, the pattern of neuronal loss in these regions correlated with the variable HD symptom profiles. CONCLUSION: The overall findings in our present and previous cortical studies establish a clear correlative pattern of variable cortical neuronal degeneration in HD pathogenesis, which mirrors the heterogeneity of HD symptom phenotypes.


Assuntos
Córtex Cerebral/patologia , Doença de Huntington/complicações , Doenças Neurodegenerativas/etiologia , Doenças Neurodegenerativas/patologia , Adulto , Idoso , Autopsia , Morte Celular , Feminino , Humanos , Doença de Huntington/genética , Interneurônios/patologia , Masculino , Pessoa de Meia-Idade
3.
Ann Neurol ; 75(5): 717-27, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24771513

RESUMO

OBJECTIVE: The cellular basis of variable symptoms in Huntington disease (HD) is unclear. One important possibility is that degeneration of the interneurons in the cerebral cortex, which play a critical role in modulating cortical output to the basal ganglia, might play a significant role in the development of variable symptomatology in HD. This study aimed to examine whether symptom variability in HD is specifically associated with variable degeneration of cortical interneurons. METHODS: We undertook a double-blind study using stereological cell counting methods to quantify the 3 major types of γ-aminobutyric acidergic interneurons (calbindin-D28k, calretinin, parvalbumin) in 13 HD cases of variable motor/mood symptomatology and 15 matched control cases in the primary motor and anterior cingulate cortices. RESULTS: In the primary motor cortex, there was a significant loss (57% reduction) of only calbindin interneurons (p=0.022) in HD cases dominated by motor symptoms, but no significant interneuron loss in cases with a dominant mood phenotype. In contrast, the anterior cingulate cortex showed a major significant loss in all 3 interneuron populations, with 71% loss of calbindin (p=0.001), 60% loss of calretinin (p=0.001), and 80% loss of parvalbumin interneurons (p=0.005) in HD cases with major mood disorder, and no interneuron loss was observed in cases with major motor dysfunction. INTERPRETATION: These findings suggest that region-specific degeneration of cortical interneurons is a key component in understanding the neural basis of symptom heterogeneity in HD.


Assuntos
Córtex Cerebral/patologia , Doença de Huntington/diagnóstico , Interneurônios/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Contagem de Células/métodos , Método Duplo-Cego , Feminino , Humanos , Doença de Huntington/epidemiologia , Doença de Huntington/patologia , Masculino , Pessoa de Meia-Idade
4.
Brain ; 133(Pt 4): 1094-110, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20375136

RESUMO

Huntington's disease is an autosomal dominant inherited neurodegenerative disease with motor symptoms that are variably co-expressed with mood and cognitive symptoms, and in which variable neuronal degeneration is also observed in the basal ganglia and the cerebral cortex. We have recently shown that the variable symptomatology in Huntington's disease correlates with the variable compartmental pattern of GABAA receptor and cell loss in the striatum. To determine whether the phenotypic variability in Huntington's disease is also related to variable neuronal degeneration in the cerebral cortex, we undertook a double-blind study using unbiased stereological cell counting methods to determine the pattern of cell loss in the primary motor and anterior cingulate cortices in the brains of 12 cases of Huntington's disease and 15 controls, and collected detailed data on the clinical symptomatology of the patients with Huntington's disease from family members and clinical records. The results showed a significant association between: (i) pronounced motor dysfunction and cell loss in the primary motor cortex; and (ii) major mood symptomatology and cell loss in the anterior cingulate cortex. This association held for both total neuronal loss (neuronal N staining) and pyramidal cell loss (SMI32 staining), and also correlated with marked dystrophic changes in the remaining cortical neurons. There was also an association between cortical cell loss and striatal neuropathological grade, but no significant association with CAG repeat length in the Huntington's disease gene. These findings suggest that the heterogeneity in clinical symptomatology that characterizes Huntington's disease is associated with variation in the extent of cell loss in the corresponding functional regions of the cerebral cortex whereby motor dysfunction correlates with primary motor cortex cell loss and mood symptomatology is associated with cell loss in the cingulate cortex.


Assuntos
Giro do Cíngulo/patologia , Doença de Huntington/diagnóstico , Doença de Huntington/patologia , Córtex Motor/patologia , Neurônios/patologia , Adulto , Idoso , Contagem de Células/métodos , Feminino , Giro do Cíngulo/citologia , Humanos , Masculino , Pessoa de Meia-Idade , Córtex Motor/citologia , Neurônios/citologia , Células Piramidais/citologia , Células Piramidais/patologia , Estudos Retrospectivos
5.
Brain ; 130(Pt 1): 206-21, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17040921

RESUMO

Variable phenotype is common in neurological disorders with single-gene inheritance patterns. In Huntington's disease, mood and cognitive symptoms are variably co-expressed with motor symptoms. There is also variable degeneration of neurons in the two major neurochemical compartments of the striatum, the striosomes and the extrastriosomal matrix. To determine whether the phenotypic variability in Huntington's disease is related to this compartmental organization, we carried out a double-blind study in which we used GABA(A) receptor immunohistochemistry to analyse the status of striosomes and matrix in the brains of 35 Huntington's disease cases and 13 control cases, and collected detailed data on the clinical symptomatology expressed by the patients from family members and records. We report here a significant association between pronounced mood dysfunction in Huntington's disease patients and differential loss of the GABA(A) receptor marker in striosomes of the striatum. This association held for both clinical onset and end-stage assessments of symptoms. The cases with accentuated striosome abnormality further exhibited later onset age, lower disease grade and lower CAG repeat length in the HD gene. We found no independent association, however, between CAG repeat length or age of onset and mood dysfunction. We suggest that variation in clinical symptomatology in Huntington's disease is associated with variation in the relative abnormality of GABA(A) receptor expression in the striosome and matrix compartments of the striatum, and that striosome-related circuits may modulate mood functioning.


Assuntos
Corpo Estriado/fisiopatologia , Doença de Huntington/fisiopatologia , Transtornos do Humor/fisiopatologia , Adulto , Idade de Início , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/análise , Método Duplo-Cego , Saúde da Família , Feminino , Humanos , Proteína Huntingtina , Doença de Huntington/genética , Doença de Huntington/psicologia , Imuno-Histoquímica/métodos , Masculino , Pessoa de Meia-Idade , Transtornos do Humor/genética , Transtornos do Humor/psicologia , Neostriado/fisiopatologia , Proteínas do Tecido Nervoso/genética , Proteínas Nucleares/genética , Fenótipo , Receptores de GABA-A/análise , Sequências Repetitivas de Ácido Nucleico/genética , Índice de Gravidade de Doença
6.
Neuroscience ; 351: 108-118, 2017 05 20.
Artigo em Inglês | MEDLINE | ID: mdl-28385633

RESUMO

Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the brain and plays an important role in regulating neuronal excitability. GABA reuptake from the synapse is dependent on specific transporters - mainly GAT-1, GAT-3 and BGT-1 (GATs). This study is the first to show alterations in the expression of the GATs in the Alzheimer's disease (AD) hippocampus, entorhinal cortex and superior temporal gyrus. We found a significant increase in BGT-1 expression associated with AD in all layers of the dentate gyrus, in the stratum oriens of the CA2 and CA3 and the superior temporal gyrus. In AD there was a significant decrease in GAT-1 expression in the entorhinal cortex and superior temporal gyrus. We also found a significant decrease in GAT-3 immunoreactivity in the stratum pyramidale of the CA1 and CA3, the subiculum and entorhinal cortex. These observations indicate that the expression of the GATs shows brain-region- and layer-specific alterations in AD, suggesting a complex activation pattern of different GATs during the course of the disease.


Assuntos
Doença de Alzheimer/metabolismo , Córtex Cerebral/metabolismo , Proteínas da Membrana Plasmática de Transporte de GABA/metabolismo , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Neurônios/metabolismo
7.
Neurobiol Aging ; 49: 214.e1-214.e5, 2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-27480424

RESUMO

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, which causes progressive and eventually fatal loss of motor function. Here, we describe genetic and pathologic characterization of brain tissue banked from 19 ALS patients over nearly 20 years at the Department of Anatomy and the Centre for Brain Research, University of Auckland, New Zealand. We screened for mutations in SOD1, TARDBP, FUS, and C9ORF72 genes and for neuropathology caused by phosphorylated TDP-43, dipeptide repeats (DPRs), and ubiquilin. We identified 2 cases with C9ORF72 repeat expansions. Both harbored phosphorylated TDP-43 and DPR inclusions. We show that DPR inclusions can incorporate or occur independently of ubiquilin. We also identified 1 case with a UBQLN2 mutation, which showed phosphorylated TDP-43 and characteristic ubiquilin protein inclusions. This is the first study of ALS genetics in New Zealand, adding New Zealand to the growing list of countries in which C9ORF72 repeat expansion and UBQLN2 mutations are detected in ALS cases.


Assuntos
Esclerose Lateral Amiotrófica/genética , Esclerose Lateral Amiotrófica/patologia , Encéfalo/patologia , Proteína C9orf72/genética , Proteínas de Ciclo Celular/genética , Expansão das Repetições de DNA/genética , Estudos de Associação Genética , Mutação/genética , Ubiquitinas/genética , Proteínas Adaptadoras de Transdução de Sinal , Adulto , Idoso , Idoso de 80 Anos ou mais , Proteínas Relacionadas à Autofagia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nova Zelândia
8.
Sci Rep ; 6: 27524, 2016 06 09.
Artigo em Inglês | MEDLINE | ID: mdl-27276998

RESUMO

Impairment of brain-glucose uptake and brain-copper regulation occurs in Alzheimer's disease (AD). Here we sought to further elucidate the processes that cause neurodegeneration in AD by measuring levels of metabolites and metals in brain regions that undergo different degrees of damage. We employed mass spectrometry (MS) to measure metabolites and metals in seven post-mortem brain regions of nine AD patients and nine controls, and plasma-glucose and plasma-copper levels in an ante-mortem case-control study. Glucose, sorbitol and fructose were markedly elevated in all AD brain regions, whereas copper was correspondingly deficient throughout (all P < 0.0001). In the ante-mortem case-control study, by contrast, plasma-glucose and plasma-copper levels did not differ between patients and controls. There were pervasive defects in regulation of glucose and copper in AD brain but no evidence for corresponding systemic abnormalities in plasma. Elevation of brain glucose and deficient brain copper potentially contribute to the pathogenesis of neurodegeneration in AD.


Assuntos
Doença de Alzheimer/metabolismo , Glicemia/metabolismo , Encéfalo/metabolismo , Cobre/deficiência , Demência/metabolismo , Polímeros/química , Idoso , Animais , Estudos de Casos e Controles , Cobre/sangue , Feminino , Frutose/química , Glucose/química , Humanos , Masculino , Espectrometria de Massas , Metais/química , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Pessoa de Meia-Idade , Probabilidade , Ratos , Ratos Wistar , Sorbitol/química , Distribuição Tecidual
9.
J Huntingtons Dis ; 3(1): 45-64, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25062764

RESUMO

Huntington's disease is an autosomal dominant neurodegenerative disease characterized by neuronal degeneration in the basal ganglia and cerebral cortex, and a variable symptom profile. Although progressive striatal degeneration is known to occur and is related to symptom profile, little is known about the cellular basis of symptom heterogeneity across the entire cerebral cortex. To investigate this, we have undertaken a double blind study using unbiased stereological cell counting techniques to determine the pattern of cell loss in six representative cortical regions from the frontal, parietal, temporal, and occipital lobes in the brains of 14 Huntington's disease cases and 15 controls. The results clearly demonstrate a widespread loss of total neurons and pyramidal cells across all cortical regions studied, except for the primary visual cortex. Importantly, the results show that cell loss is remarkably variable both within and between Huntington's disease cases. The results also show that neuronal loss in the primary sensory and secondary visual cortices relate to Huntington's disease motor symptom profiles, and neuronal loss across the associational cortices in the frontal, parietal and temporal lobes is related to both Huntington's disease motor and to mood symptom profiles. This finding considerably extends a previous study (Thu et al., Brain, 2010; 133:1094-1110) which showed that neuronal loss in the primary motor cortex was related specifically to the motor symptom profiles while neuronal loss in the anterior cingulate cortex was related specifically to mood symptom profiles. The extent of cortical cell loss in the current study was generally related to the striatal neuropathological grade, but not to CAG repeat length on the HTT gene. Overall our findings show that Huntington's disease is characterized by a heterogeneous pattern of neuronal cell loss across the entire cerebrum which varies with symptom profile.


Assuntos
Córtex Cerebral/patologia , Doença de Huntington/patologia , Neostriado/patologia , Degeneração Neural/patologia , Neurônios/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Encéfalo/patologia , Estudos de Casos e Controles , Contagem de Células , Feminino , Humanos , Doença de Huntington/fisiopatologia , Doença de Huntington/psicologia , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA